Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Run a search on a company

IOL Chemicals & Pharmaceuticals Ltd

Pharmaceuticals & Biotechnology | Small Cap

IOL Chemicals & Pharmaceuticals Ltd Health Insights
Health Score : 5.31Health Score : 5.31

IOL Chemicals & Pharmaceuticals Ltd demonstrates a mixed financial performance. The company exhibits exceptional solvency, indicating a strong ability to meet its long-term obligations. Profitability is a notable strength, driven by healthy margins and returns on capital, equity, and assets. However, growth metrics present significant challenges, with declines in revenue, operating profit, EPS, and net income. Efficiency ratios also raise concerns, reflecting issues in asset utilization and working capital management. While liquidity is reasonable, it could be improved. The company's coverage ratios are strong, suggesting a good capacity to handle interest and dividend payments. Overall, IOL Chemicals & Pharmaceuticals showcases financial stability and profitability but needs to address its growth and efficiency to ensure sustained success. The healthcare industry's dynamics, including regulatory changes and market competition, could impact the company's future performance.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overview
Ratio
Financial
IOL Chemicals & Pharmaceuticals Ltd Health Insights
Health Score : 5.31Health Score : 5.31

IOL Chemicals & Pharmaceuticals Ltd demonstrates a mixed financial performance. The company exhibits exceptional solvency, indicating a strong ability to meet its long-term obligations. Profitability is a notable strength, driven by healthy margins and returns on capital, equity, and assets. However, growth metrics present significant challenges, with declines in revenue, operating profit, EPS, and net income. Efficiency ratios also raise concerns, reflecting issues in asset utilization and working capital management. While liquidity is reasonable, it could be improved. The company's coverage ratios are strong, suggesting a good capacity to handle interest and dividend payments. Overall, IOL Chemicals & Pharmaceuticals showcases financial stability and profitability but needs to address its growth and efficiency to ensure sustained success. The healthcare industry's dynamics, including regulatory changes and market competition, could impact the company's future performance.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Undervalued

Overall Valuation Score

Highly Undervalued
Undervalued
Neutral
Overvalued
Highly Overvalued
Undervalued

P/E RATIO (TTM)

27.76

Neutral

Industry Median

28.62

Neutral
Neutral

Small Cap Median

27.17

Neutral

P/E RATIO

27.76

P/B RATIO

2.12

Undervalued

Industry Median

3.17

Undervalued
Neutral

Small Cap Median

2.62

Neutral

P/S RATIO

1.61

Undervalued

Industry Median

3.42

Undervalued
Undervalued

Small Cap Median

2.55

Undervalued

Others

Highly Undervalued

PEG RATIO

-5.78

Highly Undervalued
Overvalued

EV/EBITDA RATIO

12.71

Overvalued

The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹130.21 as on Jun 21, 2026.

Markets Depth NSE

Buy Orders

  1. Bid

    Quantity

    Orders

  2. No buy depth

  3. Total

    0

    0

Sell Orders

  1. Ask

    Quantity

    Orders

  2. No sell depth

  3. Total

    0

    0

BidsOffers
50.00%50.00%

Markets Today NSE

  1. High

    0.00

  2. Low

    0.00

  3. Open

    0.00

  4. Close

    0.00

  5. Prev Close

    0.00

  6. Avg Price

    0.00

  7. Volume

    0

  8. Last Traded Quantity

    0

  9. Last Traded Time

    N/A

Price Movement Indicator

0.00

0.00
Today's Low

0.00
Today's High

Growth Ratio Summary
Growth Ratio SummaryGrowth Score : 2.80

The growth ratios present a concerning picture of the company's recent performance. Revenue, operating profit, EPS, and net income have all experienced declines, indicating significant challenges in expanding the business. The asset growth rate is positive, suggesting some level of investment, but this is overshadowed by the negative trends in other key growth metrics. The company needs to address these issues to regain positive momentum.

PoorRevenue Growth RatePoor
PoorOperating Profit Growth RatePoor
PoorEarnings Per Share (EPS) GrowthPoor
ExcellentAsset Growth RateExcellent
PoorNet Income Growth RatePoor
Growth RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue Growth Rate1.51-3.79-2.5311.54
Operating Profit Growth Rate-12.742.21-12.5533.17
Earnings Per Share (EPS) Growth-16.99-3.38-24.8936.34
Asset Growth Rate3.0610.986.158.61
Net Income Growth Rate-17.26-3.6-24.6336.63
01.

Revenue Growth Rate

02.

Operating Profit Growth Rate

03.

Earnings Per Share (EPS) Growth

04.

Asset Growth Rate

05.

Net Income Growth Rate

Financial Ratio Summary
Financial Ratio SummaryFinancial Score : 3.40

The financial ratios present a mixed picture of the company's financial health. Adjusted EPS and cash EPS are low, indicating moderate profitability on a per-share basis. Book value per share is also moderate. Dividend per share is reasonable, but capital expenditures are high, reflecting significant investments. Overall, the company shows potential but needs to improve its financial performance.

PoorAdjusted Earnings Per Share (Adjusted EPS)Poor
WeakCash Earnings Per Share (Cash EPS)Weak
WeakBook Value Per ShareWeak
AverageDividend Per Share (DPS)Average
PoorCapital Expenditures (CapEx)Poor
Financial RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Adjusted Earnings Per Share (Adjusted EPS)6.074.714.543.424.95
Cash Earnings Per Share (Cash EPS)7.156.276.685.867.39
Book Value Per Share47.2251.1254.6457.2260.98
Dividend Per Share (DPS)0.80.811.010.790.98
Capital Expenditures (CapEx)151210272213171
01.

Adjusted Earnings Per Share (Adjusted EPS)

02.

Cash Earnings Per Share (Cash EPS)

03.

Book Value Per Share

04.

Dividend Per Share (DPS)

05.

Capital Expenditures (CapEx)

Profitability Ratio Summary
Profitability Ratio SummaryProfitability Score : 9.80

The profitability ratios indicate strong performance across various metrics. Gross profit margin, ROCE, ROE, ROA, operating margin, and net margin all suggest efficient operations and effective management. The company is generating healthy profits from its sales, capital employed, equity, and assets. This reflects positively on its financial health and sustainability.

ExcellentGross Profit MarginExcellent
ExcellentReturn on Capital Employed (ROCE)Excellent
ExcellentReturn on Equity (ROE)Excellent
GoodReturn on Assets (ROA)Good
ExcellentOperating MarginExcellent
ExcellentNet MarginExcellent
Profitability RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Profit Margin9.898.127.886.258.15
Return on Capital Employed (ROCE)16.711412911
Return on Equity (ROE)12.069.228.315.987.67
Return on Assets (ROA)13.211.1810.298.4810.4
Operating Margin11.8610.1910.839.7211.6
Net Margin7.696.276.284.865.95
01.

Gross Profit Margin

02.

Return on Capital Employed (ROCE)

03.

Return on Equity (ROE)

04.

Return on Assets (ROA)

05.

Operating Margin

06.

Net Margin

Efficiency Ratio Summary
Efficiency Ratio SummaryEfficiency Score : 3.33

The efficiency ratios suggest some challenges in asset utilization and working capital management. Inventory and receivables turnover ratios indicate areas for improvement in managing inventory and collecting payments. Receivable days and days sales in inventory are high, suggesting inefficiencies in these areas. However, the fixed asset turnover ratio is low, reflecting potential underutilization of fixed assets.

PoorFixed Asset Turnover RatioPoor
AverageInventory Turnover RatioAverage
WeakReceivables Turnover RatioWeak
WeakDays Sales in Inventory RatioWeak
PoorReceivable DaysPoor
PoorCapital Turnover RatioPoor
Efficiency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Fixed Asset Turnover Ratio3.892.952.291.781.96
Inventory Turnover Ratio4.85.545.234.965.82
Receivables Turnover Ratio4.624.554.374.224.15
Days Sales in Inventory Ratio76.0465.8869.7973.5962.71
Receivable Days7980.2283.5286.4987.95
Capital Turnover Ratio1.571.471.321.231.29
01.

Fixed Asset Turnover Ratio

02.

Inventory Turnover Ratio

03.

Receivables Turnover Ratio

04.

Days Sales in Inventory Ratio

05.

Receivable Days

06.

Capital Turnover Ratio

Coverage Ratio Summary
Coverage Ratio SummaryCoverage Score : 8.40

The coverage ratios indicate a strong capacity to meet interest and dividend obligations. The interest coverage ratio suggests the company can comfortably cover its interest expenses with its earnings. The equity dividend coverage ratio also suggests a reasonable ability to cover dividend payments. Overall, the company demonstrates financial stability in meeting its obligations.

ExcellentInterest Coverage RatioExcellent
AverageEquity Dividend Coverage RatioAverage
Coverage RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Interest Coverage Ratio29.1212.8112.3810.213.27
Equity Dividend Coverage Ratio7.145.884.554.354.76
01.

Interest Coverage Ratio

02.

Equity Dividend Coverage Ratio

Solvency Ratio Summary
Solvency Ratio SummarySolvency Score : 10.00

The solvency position is exceptionally strong, indicating a robust ability to meet long-term obligations. The company exhibits no debt, resulting in high equity and asset ratios. This conservative capital structure reduces financial risk and enhances financial stability. A debt-free status provides flexibility for future investments and growth opportunities.

ExcellentDebt RatioExcellent
ExcellentDebt to Equity RatioExcellent
ExcellentEquity RatioExcellent
ExcellentDebt To Asset RatioExcellent
Solvency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debt Ratio00000
Debt to Equity Ratio00000
Equity Ratio11111
Debt To Asset Ratio00000
01.

Debt Ratio

02.

Debt to Equity Ratio

03.

Equity Ratio

04.

Debt To Asset Ratio

Liquidity Ratio Summary
Liquidity Ratio SummaryLiquidity Score : 5.86

The liquidity position indicates a mixed ability to meet short-term obligations. The quick ratio suggests reasonable capacity to cover immediate liabilities, excluding inventory. However, the cash ratio and operating cash flow ratio indicate potential challenges in relying solely on cash and operating cash flows for short-term needs. While adequate, there is room for improvement in managing current assets and liabilities.

AverageCurrent RatioAverage
GoodQuick RatioGood
WeakCash RatioWeak
WeakOperating Cash Flow RatioWeak
Liquidity RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Current Ratio2.272.251.881.681.64
Quick Ratio1.551.621.211.161.17
Cash Ratio0.250.040.230.30.25
Operating Cash Flow Ratio0.160.240.460.260.27
01.

Current Ratio

02.

Quick Ratio

03.

Cash Ratio

04.

Operating Cash Flow Ratio

Peer Comparison With 20 Companies

Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.

NO Company Name Health Score P/E Ratio Valuation OPM EPS Latest Profit & Loss
1Jagsonpal Pharmaceuticals Ltd8.5133.01Overvalued58.006.4243.00
2Amrutanjan Health Care Ltd8.2577.37Highly Overvalued31.0020.0321.00
3Windlas Biotech Ltd7.5225.92Neutral105.0032.1966.00
4Innova Captab Ltd7.3638.55Overvalued243.0014.63141.00
5Hikal Ltd7.13-51.71Neutral220.00-3.95-49.00
6RPG Life Sciences Ltd7.1232.70Neutral147.0069.64115.00
7Morepen Laboratories Ltd7.1228.61Neutral126.001.2196.00
8Alembic Ltd7.067.28Undervalued90.004.85317.00
9Syncom Formulations (India) Ltd6.9217.27Undervalued77.000.8176.00
10Hester Biosciences Ltd6.5431.74Neutral87.0061.2457.00
11Sigachi Industries Ltd6.4911.55Highly Undervalued54.00-2.08-83.00
12SMS Pharmaceuticals Ltd5.9434.77Neutral171.009.35102.00
13Gufic BioSciences Ltd5.4955.51Neutral151.006.3064.00
14Dishman Carbogen Amcis Ltd5.3827.45Neutral566.00-2.4597.00
15IOL Chemicals & Pharmaceuticals Ltd5.3127.76Undervalued269.004.69138.00
16Indoco Remedies Ltd5.26-22.79Neutral142.00-0.61-99.00
17Aarti Drugs Ltd5.0717.34Undervalued309.0018.54195.00
18Orchid Pharma Ltd4.85241.74Neutral41.008.9121.00
19Solara Active Pharma Sciences Ltd4.34-274.68Neutral187.00-1.50-7.00
Management Assessment Summary
OrangeBalanced Management

IOL Chemicals & Pharmaceuticals Ltd's management effectiveness presents a mixed outlook. Strengths are evident in the increasing promoter holding, demonstrating confidence. However, there are concerns regarding declining profit growth and recent sales contraction. Efficient cash conversion is a positive aspect, but declining profitability trends need attention for long-term value creation.

Category Metric Value Assessment
PROS Promoter Holding 52.62% Indicates confidence
Cash Conversion Cycle 73 Days Efficient working capital management
CONS Compounded Profit Growth (3Y) -17% Declining profit growth
Sales Growth % (Mar 2025) -2.51% Recent revenue contraction
AverageFinancial Performance & GrowthAverage
WeakCapital Efficiency & ReturnsWeak
AverageFinancial Health & PrudenceAverage
GoodShareholding & Ownership StructureGood
01.

Financial Performance & Growth

02.

Capital Efficiency & Returns

03.

Financial Health & Prudence

04.

Shareholding & Ownership Structure

Risk Assessment Summary
OrangeBalanced Risk

The risk assessment for IOL Chemicals & Pharmaceuticals Ltd. indicates a moderate level of risk. Segment performance volatility is evident with fluctuating quarterly sales and profit growth. The increasing borrowings and decreasing ROCE highlight potential financial strain. Foreign exchange or interest rate exposure may pose additional risks, given the company's operations and debt levels.

AverageSegment performance volatilityAverage
AverageForeign exchange or interest rate exposureAverage
01.

Segment performance volatility

02.

Foreign exchange or interest rate exposure

0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10129.77Bullish
  3. SMA 20128.14Bullish
  4. SMA 50129.53Bullish
  5. EMA 10129.74Bullish
  6. EMA 20129.16Bullish
  7. EMA 50129.34Bullish
  8. DEMA 10130.58Bearish
  9. DEMA 20129.60Bullish
  10. DEMA 50129.00Bullish
  11. TEMA 10130.75Bearish
  12. TEMA 20130.56Bearish
  13. TEMA 50127.97Bullish
  14. MACD0.46Bullish
  15. ADX22.39Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI55.14Neutral
  3. CCI69.71Neutral
  4. ROC 91.65Bullish
  5. ROC 143.29Bullish
  6. ROC 253.09Bullish
  7. Stoch K72.18Neutral
  8. Stoch D76.18Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper133.12Neutral
  3. BB Middle128.14Neutral
  4. BB Lower123.16Neutral
  5. ATR1.87Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI74.72Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10128.62Bullish
  3. SMA 20128.76Bullish
  4. SMA 50130.61Bearish
  5. EMA 10129.15Bullish
  6. EMA 20129.10Bullish
  7. EMA 50128.80Bullish
  8. DEMA 10129.74Bullish
  9. DEMA 20128.68Bullish
  10. DEMA 50131.50Bearish
  11. TEMA 10130.59Bearish
  12. TEMA 20128.90Bullish
  13. TEMA 50128.19Bullish
  14. MACD-0.17Bullish
  15. ADX20.44Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI53.02Neutral
  3. CCI34.50Neutral
  4. ROC 94.41Bullish
  5. ROC 142.76Bullish
  6. ROC 251.57Bullish
  7. Stoch K72.22Neutral
  8. Stoch D65.09Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper134.99Neutral
  3. BB Middle128.76Neutral
  4. BB Lower122.53Neutral
  5. ATR2.75Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI53.29Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10128.55Bullish
  3. SMA 20129.78Bullish
  4. SMA 50126.41Bullish
  5. EMA 10128.97Bullish
  6. EMA 20129.09Bullish
  7. EMA 50123.84Bullish
  8. DEMA 10128.59Bullish
  9. DEMA 20129.95Bullish
  10. DEMA 50136.07Bearish
  11. TEMA 10128.83Bullish
  12. TEMA 20127.57Bullish
  13. TEMA 50N/AN/A
  14. MACD0.46Bearish
  15. ADX24.72Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI53.12Neutral
  3. CCI-6.13Neutral
  4. ROC 9-2.19Bearish
  5. ROC 140.20Bullish
  6. ROC 250.12Bullish
  7. Stoch K39.30Neutral
  8. Stoch D33.60Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper135.49Neutral
  3. BB Middle129.78Neutral
  4. BB Lower124.07Neutral
  5. ATR4.62Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI52.92Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (22)
  1. IndicatorValueSignal
  2. SMA 10129.46Bullish
  3. SMA 20129.49Bullish
  4. SMA 50109.63Bullish
  5. SMA 10091.73Bullish
  6. SMA 20092.50Bullish
  7. EMA 10128.99Bullish
  8. EMA 20126.01Bullish
  9. EMA 50112.95Bullish
  10. EMA 100101.45Bullish
  11. EMA 20094.05Bullish
  12. DEMA 10129.93Bullish
  13. DEMA 20134.11Bearish
  14. DEMA 50130.59Bearish
  15. DEMA 100115.09Bullish
  16. DEMA 200102.25Bullish
  17. TEMA 10127.88Bullish
  18. TEMA 20131.57Bearish
  19. TEMA 50138.53Bearish
  20. TEMA 100126.86Bullish
  21. TEMA 200108.82Bullish
  22. MACD5.40Bearish
  23. ADX42.85Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI57.92Neutral
  3. CCI-6.09Neutral
  4. ROC 143.45Bullish
  5. ROC 2519.08Bullish
  6. Stoch K32.54Neutral
  7. Stoch D31.84Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper137.90Neutral
  3. BB Middle129.49Neutral
  4. BB Lower121.08Neutral
  5. ATR7.39Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI64.09Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Trend Indicators (10)
  1. IndicatorValueSignal
  2. SMA 2090.78Bullish
  3. SMA 5091.80Bullish
  4. EMA 20100.02Bullish
  5. EMA 5091.31Bullish
  6. DEMA 20112.93Bullish
  7. DEMA 5097.89Bullish
  8. TEMA 20124.07Bullish
  9. TEMA 50102.94Bullish
  10. MACD11.46Bullish
  11. ADX34.94Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI72.94Overbought
  3. CCI227.63Overbought
  4. ROC 1481.45Bullish
  5. ROC 2563.09Bullish
  6. Stoch K88.95Overbought
  7. Stoch D86.62Overbought
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper133.09Overbought
  3. BB Middle90.78Neutral
  4. BB Lower48.46Neutral
  5. ATR11.01High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI97.11Overbought

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 687.57Bullish
  3. SMA 1291.82Bullish
  4. SMA 2484.78Bullish
  5. EMA 696.37Bullish
  6. EMA 1290.60Bullish
  7. EMA 2486.86Bullish
  8. DEMA 6105.46Bullish
  9. DEMA 1296.60Bullish
  10. DEMA 2490.97Bullish
  11. TEMA 6112.78Bullish
  12. TEMA 12100.85Bullish
  13. TEMA 2494.09Bullish
  14. MACD5.71Bullish
  15. ADX18.06Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI59.04Neutral
  3. CCI270.21Overbought
  4. ROC 2563.80Bullish
  5. ROC 5082.33Bullish
  6. Stoch K51.49Neutral
  7. Stoch D44.44Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper116.55Overbought
  3. BB Middle84.22Neutral
  4. BB Lower51.89Neutral
  5. ATR19.37High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI76.87Neutral